Actos (Pioglitazone)

Actos is a medicine used to help control blood sugar levels in people with type 2 diabetes. It works by helping the body use insulin better. It's taken by mouth, usually once a day.

Brand names:Actos
Medication

What people taking Actos (Pioglitazone) report

Every report comes from a Lived member, sent anonymously.

Have you tried Actos (Pioglitazone) for Type 2 Diabetes?

NameHow it went

About Actos (Pioglitazone)

What It's For

Pioglitazone, sold under the brand name Actos and as a generic, is a prescription tablet that lowers blood sugar in adults with type 2 diabetes. It is used alongside eating and activity changes, either on its own or together with other diabetes medicines such as metformin, a sulfonylurea or insulin. It belongs to a class of medicines called thiazolidinediones. Pioglitazone also comes in combination tablets: Actoplus Met (with metformin), Duetact (with glimepiride, a sulfonylurea) and Oseni (with alogliptin, another type of diabetes pill called a DPP-4 inhibitor). Each combination carries the cautions of its partner medicine as well. Because pioglitazone only works when the body still makes some of its own insulin, it is not used for type 1 diabetes or for diabetic ketoacidosis, a dangerous buildup of acids caused by a severe lack of insulin. For people with type 2 diabetes who also have MASH, an inflammatory form of fatty liver disease, the American Diabetes Association says pioglitazone can be considered partly because of its potential benefit for the liver.

How It Works

In type 2 diabetes, the pancreas usually still makes insulin, but muscle, fat and liver cells respond to it poorly. This is called insulin resistance, and it leaves more sugar circulating in the blood. Pioglitazone activates a receptor inside cells called PPAR-gamma, which switches on genes involved in handling sugar and fat. As a result, muscle and fat take up more sugar in response to insulin, and the liver releases less sugar into the bloodstream. Because it makes existing insulin work better rather than pushing the pancreas to release more, pioglitazone is not expected to cause low blood sugar by itself; that risk comes mainly when it is combined with insulin or a sulfonylurea. In trials it also tended to lower triglycerides and raise HDL ("good") cholesterol, with no consistent change in LDL cholesterol.

Dosage & Administration

Pioglitazone is a tablet taken once a day, with or without food. Prescribers usually start with 15 or 30 mg and may raise the dose in 15 mg steps, up to 45 mg a day, based on how much the HbA1c falls. HbA1c is a blood test that reflects average blood sugar over roughly the past three months. People who have mild heart failure start at 15 mg. A liver blood test is done before starting. If a dose is missed, it can be taken later the same day, but the next day's dose should not be doubled. Combination tablets have their own dosing instructions, so follow those for the exact product prescribed.

Side Effects

In trials, the most common side effects were cold-like infections, sinus infections, sore throat, headache and muscle aches. Weight gain and swelling (edema), especially in the ankles and lower legs, are also common. Both become more likely at higher doses and when pioglitazone is taken with insulin. Because fluid buildup can strain the heart, contact the prescriber promptly about rapid weight gain, new or worsening swelling, or shortness of breath, particularly after starting or increasing the dose. Women taking pioglitazone have a higher risk of broken bones, mostly in the arms and legs rather than the spine. In a large trial lasting about three years, roughly 5 in 100 women taking it had a fracture, compared with about 2.5 in 100 taking a placebo. No increase was seen in men. Serious liver injury, including liver failure, has been reported rarely, although it is not certain the medicine was the cause. Stop taking it and get medical advice promptly for unexplained nausea, vomiting, stomach pain, unusual tiredness, loss of appetite, dark urine or yellowing of the skin or eyes. Blurred vision or other vision changes should also be checked promptly, since swelling in the retina (macular edema) has been reported with this class of medicine.

Interactions & Warnings

Pioglitazone carries an FDA boxed warning, the agency's most prominent, because it can cause or worsen heart failure by making the body hold onto fluid. It is not recommended for people with heart failure that causes symptoms, and it must not be started in people whose heart failure is severe enough that they are comfortable only at rest. The risk is higher when it is combined with insulin. Taken with insulin or a sulfonylurea (such as glimepiride, a pill that prompts the pancreas to release insulin), it can lead to low blood sugar, so the dose of those medicines may need to be lowered. Gemfibrozil, a cholesterol-lowering medicine, roughly triples pioglitazone levels, so the pioglitazone dose is limited to 15 mg when the two are taken together. The antibiotic rifampin can lower pioglitazone levels and weaken its effect. Pioglitazone may increase the risk of bladder cancer, although studies disagree. It is not used by people with active bladder cancer, and a past history calls for a careful discussion of benefits and unknowns. Report visible blood in the urine, or new or worsening pain or urgency when urinating. In premenopausal women who do not ovulate regularly, pioglitazone can restart ovulation, making an unplanned pregnancy possible, so contraception is worth discussing. Human data in pregnancy and breastfeeding are limited, so tell the prescriber about pregnancy, plans for pregnancy or breastfeeding.

What to Expect

Pioglitazone works slowly. Blood sugar may start to come down within about two weeks, but the full effect can take two to three months, so whether it is working is judged over months by HbA1c rather than by day-to-day readings. In trials it lowered HbA1c both on its own and when added to metformin, a sulfonylurea or insulin. Ongoing care includes regular HbA1c checks, keeping an eye on weight and swelling, routine eye exams and attention to bone health, particularly for women. Repeat liver tests are not routinely needed for people without liver disease, but symptoms that suggest a liver problem call for testing. Illness, infection, injury or surgery can change medication needs, so check in with the care team at those times. Pioglitazone controls blood sugar but does not cure diabetes, and it has not been conclusively shown to lower the risk of heart attack or stroke. Keep taking it even when feeling well, and do not stop without talking with the prescriber.

Questions to Ask Your Doctor

  1. 1.Why is pioglitazone a good fit for me compared with other diabetes medicines, and does my liver health play a part?
  2. 2.Does my heart health make fluid retention a concern, and how much weight gain or swelling should prompt a call?
  3. 3.Do any of my other diabetes medicines need adjusting to avoid low blood sugar?
  4. 4.Given my history, what do the fracture and bladder cancer risks mean for me?
  5. 5.How and when will we decide whether it is working well enough to continue?

Last reviewed • Oct 2026

Educational content, not medical advice.